Brainsway stock sale pulls in about $67.6M

10/7/2013 | Globes (Israel)

Brainsway, maker of the Deep Transcranial Magnetic Stimulation, or TMS, device designed to treat depression, has secured about $6.76 million in a shares offering in Israel. Over the weekend, the company also obtained $1 million in initial payments from a Japanese distributor that agreed to market its depression systems.

View Full Article in:

Globes (Israel)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA